JNJ · Earnings call · 2026Q3T · Full report

Middle East MedTech Demand

JOHNSON & JOHNSON · 2026-10-13 · Importance 40 · Surprise 42

Johnson & Johnson said Middle East-related disruption has broadened beyond a few markets and is affecting ordering patterns, tender timing, and spending decisions across a wider group of countries. Governments and health care systems are taking longer to make funding and procurement decisions, creating a more meaningful impact on MedTech purchasing behavior than earlier in 2026. Management characterized the issue as a short-term factor and expects many deferred opportunities to return rather than be permanently lost. The company also cited the Middle East as an incremental pressure on international surgery alongside transformation-program and volume-based-procurement effects.

Key facts

• Johnson & Johnson said they expect many of the opportunities impacted by the Middle East disruptions to be deferred rather than permanently lost.
• Johnson & Johnson said the effect of the Middle East situation has broadened over time and is no longer limited to a few markets, with increased disruption to ordering patterns, tender timing, and spending decisions across a wider group of countries.
• Johnson & Johnson said governments and health care systems have become more cautious in their spending priorities and that some funding and procurement decisions are taking longer than normally expected.